Year: 1994
Type: article
Abstract: Over the past 30 years, hepatitis C has emerged from sh :e of the etiological agent of this disease was first appreciated tw, ~wait its molecular characterization within the past 5 years.The v oximately 20% of clinical viral hepatitis in the United States.W nd blood products has been nothing less than spectacular, the c ge to the scientific and medical communities. ds: Hepatitis C; Flavivirus; Non-A non-B hepatitis; Transmissio~ EvWhile the control of the transmissk control of community-acquired he Transmission studies Evidence for an additional hc ientific achievements Epidemiological studies of .'loningand sequenc-hepatitis and experimental t (HCV) [1], formerly of hepatitis in volunteers dur kNB) hepatitis virus, and 1960s suggested that tlachieved without a only two, etiological agents o tony people over the terically transmitted infectiot pid rate of progress atitis A, and parenterally traT the foundation for atitis, or hepatitis B. Infectio place and ready for agents was thought to confer • The following is a heterologous immunity.Thes and characterization formed at a time when th sensitive tests for liver diseas{ ical markers of the viruses, a atitis was made on the basis c and the detection of elevate, Thus, it is not surprising tha 01) 496 6227-Fax: (301) ture of viral hepatitis emerge early studies, however, more challenge
Source: FEMS Microbiology Reviews
Author: R Purcell
Language: English
Topic: Hepatitis C virus research
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2067254060